Literature DB >> 33883675

SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy.

Marta Giovanetti1,2,3, Eleonora Cella4, Francesca Benedetti5, Brittany Rife Magalis6, Vagner Fonseca2,7,8, Silvia Fabris3, Giovanni Campisi9, Alessandra Ciccozzi3, Silvia Angeletti10, Alessandra Borsetti11, Vittoradolfo Tambone12, Caterina Sagnelli13, Stefano Pascarella14, Alberto Riva15, Giancarlo Ceccarelli16, Alessandro Marcello17, Taj Azarian4, Eduan Wilkinson7, Tulio de Oliveira7, Luiz Carlos Junior Alcantara1,2, Roberto Cauda18, Arnaldo Caruso9, Natalie E Dean19, Cameron Browne20, Jose Lourenco21, Marco Salemi22, Davide Zella23, Massimo Ciccozzi24.   

Abstract

We investigated SARS-CoV-2 transmission dynamics in Italy, one of the countries hit hardest by the pandemic, using phylodynamic analysis of viral genetic and epidemiological data. We observed the co-circulation of multiple SARS-CoV-2 lineages over time, which were linked to multiple importations and characterized by large transmission clusters concomitant with a high number of infections. Subsequent implementation of a three-phase nationwide lockdown strategy greatly reduced infection numbers and hospitalizations. Yet we present evidence of sustained viral spread among sporadic clusters acting as "hidden reservoirs" during summer 2020. Mathematical modelling shows that increased mobility among residents eventually catalyzed the coalescence of such clusters, thus driving up the number of infections and initiating a new epidemic wave. Our results suggest that the efficacy of public health interventions is, ultimately, limited by the size and structure of epidemic reservoirs, which may warrant prioritization during vaccine deployment.

Entities:  

Year:  2021        PMID: 33883675     DOI: 10.1038/s42003-021-02025-0

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  10 in total

1.  Two Years of Evolutionary Dynamics of SARS-CoV-2 in Mexico, With Emphasis on the Variants of Concern.

Authors:  Alejandro Flores-Alanis; Gabriela Delgado; Luis F Espinosa-Camacho; Flor Rodríguez-Gómez; Armando Cruz-Rangel; Luisa Sandner-Miranda; Alejandro Cravioto; Rosario Morales-Espinosa
Journal:  Front Microbiol       Date:  2022-07-05       Impact factor: 6.064

Review 2.  Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19.

Authors:  Caterina Sagnelli; Antonello Sica; Massimiliano Creta; Alessandra Borsetti; Massimo Ciccozzi; Evangelista Sagnelli
Journal:  Pathogens       Date:  2022-05-11

3.  SARS-CoV-2 Pandemic Tracing in Italy Highlights Lineages with Mutational Burden in Growing Subsets.

Authors:  Angelo Boccia; Rossella Tufano; Veronica Ferrucci; Leandra Sepe; Martina Bianchi; Stefano Pascarella; Massimo Zollo; Giovanni Paolella
Journal:  Int J Mol Sci       Date:  2022-04-09       Impact factor: 6.208

4.  Early Emergence Phase of SARS-CoV-2 Delta Variant in Florida, US.

Authors:  Eleonora Cella; Sobur Ali; Sarah E Schmedes; Brittany Rife Magalis; Simone Marini; Marco Salemi; Jason Blanton; Taj Azarian
Journal:  Viruses       Date:  2022-04-06       Impact factor: 5.818

5.  Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients.

Authors:  Letizia Santinelli; Luca Laghi; Giuseppe Pietro Innocenti; Claudia Pinacchio; Paolo Vassalini; Luigi Celani; Alessandro Lazzaro; Cristian Borrazzo; Massimiliano Marazzato; Lorenzo Tarsitani; Alexia E Koukopoulos; Claudio M Mastroianni; Gabriella d'Ettorre; Giancarlo Ceccarelli
Journal:  Front Nutr       Date:  2022-01-12

Review 6.  Renal involvement in COVID-19: focus on kidney transplant sector.

Authors:  Caterina Sagnelli; Antonello Sica; Monica Gallo; Massimiliano Creta; Gaia Peluso; Filippo Varlese; Vincenzo D'Alessandro; Massimo Ciccozzi; Felice Crocetto; Carlo Garofalo; Alfonso Fiorelli; Gabriella Iannuzzo; Alfonso Reginelli; Fabrizo Schonauer; Michele Santangelo; Evangelista Sagnelli; Armando Calogero
Journal:  Infection       Date:  2021-10-05       Impact factor: 3.553

7.  Diagnostic performance of a colorimetric RT -LAMP for the identification of SARS-CoV-2: A multicenter prospective clinical evaluation in sub-Saharan Africa.

Authors:  Marycelin Mandu Baba; Molalegne Bitew; Joseph Fokam; Eric Agola Lelo; Ahmed Ahidjo; Kominist Asmamaw; Grace Angong Beloumou; Wallace Dimbuson Bulimo; Emanuele Buratti; Collins Chenwi; Hailu Dadi; Pierlanfranco D'Agaro; Laura De Conti; Nadine Fainguem; Galadima Gadzama; Paolo Maiuri; Janet Majanja; Wadegu Meshack; Alexis Ndjolo; Celine Nkenfou; Bamidele Soji Oderinde; Silvanos Mukunzi Opanda; Ludovica Segat; Cristiana Stuani; Samwel L Symekher; Desire Takou; Kassahun Tesfaye; Gianluca Triolo; Keyru Tuki; Serena Zacchigna; Alessandro Marcello
Journal:  EClinicalMedicine       Date:  2021-08-28

8.  Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020.

Authors:  Alessia Lai; Annalisa Bergna; Stefano Toppo; Marina Morganti; Stefano Menzo; Valeria Ghisetti; Bianca Bruzzone; Mauro Codeluppi; Vito Fiore; Emmanuele Venanzi Rullo; Guido Antonelli; Loredana Sarmati; Gaetano Brindicci; Annapaola Callegaro; Caterina Sagnelli; Daniela Francisci; Ilaria Vicenti; Arianna Miola; Giovanni Tonon; Daniela Cirillo; Ilaria Menozzi; Sara Caucci; Francesco Cerutti; Andrea Orsi; Roberta Schiavo; Sergio Babudieri; Giuseppe Nunnari; Claudio M Mastroianni; Massimo Andreoni; Laura Monno; Davide Guarneri; Nicola Coppola; Andrea Crisanti; Massimo Galli; Gianguglielmo Zehender
Journal:  Sci Rep       Date:  2022-04-06       Impact factor: 4.379

9.  Low-frequency variants in mildly symptomatic vaccine breakthrough infections presents a doubled-edged sword.

Authors:  Brittany R Magalis; Carla Mavian; Massimiliano Tagliamonte; Shannan N Rich; Melanie Cash; Alberto Riva; Julia C Loeb; Michael Norris; David M Amador; Yanping Zhang; Jerne Shapiro; Petr Starostik; Simone Marini; Paul Myers; David A Ostrov; John A Lednicky; J Glenn Morris; Michael Lauzardo; Marco Salemi
Journal:  J Med Virol       Date:  2022-04-13       Impact factor: 20.693

Review 10.  The variants question: What is the problem?

Authors:  Davide Zella; Marta Giovanetti; Francesca Benedetti; Francesco Unali; Silvia Spoto; Michele Guarino; Silvia Angeletti; Massimo Ciccozzi
Journal:  J Med Virol       Date:  2021-07-28       Impact factor: 20.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.